Recent research focusing on Retatrutide at a dosage of 30mg is shedding new light on its potential effects. Early findings suggest that this higher dosage may amplify the drug's ability to control blood sugar, potentially offering improved outcomes for individuals with diabetes. Further research is underway to fully understand the long-term safety